Home > Insider Trading > Filing (0001209191-14-046017)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1552047	L Kenneth Horton	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp & Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-07-01	28,321	$45.11	62,597	No	4	M	Direct
Common Stock	Disposition	2014-07-01	2,257	$94.49	60,340	No	4	S	Direct
Common Stock	Disposition	2014-07-01	27,877	$95.28	32,463	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-07-01	28,321	$0.00	28,321	$45.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
62,304	2013-05-05	2023-02-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	366	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $94.49 (range $93.79 to $94.78).
Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $95.28 (range $94.79 to $95.66).
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/2013.